Labiana Health S.A (LAB) | Stock Overview & Key Data
Labiana Health S.A. | Small-cap | Healthcare
Labiana Health S.A. | Small-cap | Healthcare
Labiana Health S.A Performance Comparison
Stock Range
Today's Range
Low: €4.00
High: €4.18
on September 23, 2025
52 Week Range
Low: €1.86
High: €4.40
on November 12, 2024
on September 5, 2025
All-Time High: €4.40 on September 2, 2025
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Market Cap
€28.9M
EPS
0.04
P/E Ratio (TTM)
104.00
Forward P/E
4.44
P/B Ratio
6.26
PEG Ratio
N/A
Div. Yield
N/A
ROE
6.92%
Beta
-0.388
Debt to Equity
1,378.08
Financial Highlights
Profitability
Gross Margin
147.79%
Operating Margin
3.32%
Profit Margin
0.38%
Returns and Earnings
Return on Assets (TTM)
5.72%
Return on Equity (TTM)
6.92%
EBITDA
€9.3M
Net Income (TTM)
€253.5K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€9.33
Quarterly Revenue Growth (YoY)
4.00%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Labiana Health S.A LAB | 28.89M Small-cap | 0.00% | 2.04% | 9.89% | 35.14% | 36.05% | 60.00% | 13,233.33% | 640.74% |
| Laboratorios ROVI | 3.04B Large-cap | -1.84% | 1.82% | 8.89% | 11.79% | -8.13% | -18.56% | 33.03% | 89.68% |
| Almirall S.A ALM | 2.49B Large-cap | 3.76% | 3.57% | 9.23% | 14.51% | 38.42% | 31.07% | 17.65% | 20.08% |
| Faes Farma S.A FAE | 1.31B Large-cap | 0.47% | -0.24% | -6.19% | 20.11% | 20.80% | 14.29% | 14.29% | 26.19% |
| Laboratorio Reig RJF | 229.52M Mid-cap | -0.35% | -4.05% | -8.09% | 7.58% | 10.51% | 3.65% | 25.66% | -33.18% |
| Grifols, S.A GRF | 7.45B Large-cap | -0.83% | -3.95% | 17.57% | 29.60% | 25.90% | 17.34% | 34.12% | -52.40% |
Ownership & Short Interest
Insider Ownership
72.21%
Institutional Ownership
0.11%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2K
Average 90-Day Volume
3K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LAB's 52-week high and low?
- In the last 52 weeks, Labiana Health S.A reached a high of €4.40 (on September 5, 2025) and a low of €1.86 (on November 12, 2024).
- What is the market cap and P/E ratio for LAB?
- Curious about Labiana Health S.A's size and valuation? Its market capitalization stands at 28.89M. When it comes to valuation, the P/E ratio (trailing twelve months) is 104.00, and the forward P/E (looking ahead) is 4.44.
- Does LAB pay dividends? If so, what's the yield?
- As for dividends, Labiana Health S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Labiana Health S.A's main competitors or similar companies to consider before investing?
When looking at Labiana Health S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI3.04B Healthcare Drug Manufacturers - Specialty & Generic -18.56% 33.03% Almirall S.A
ALM2.49B Healthcare Drug Manufacturers - Specialty & Generic 31.07% 17.65% Faes Farma S.A
FAE1.31B Healthcare Drug Manufacturers - Specialty & Generic 14.29% 14.29% Laboratorio Reig
RJF229.52M Healthcare Drug Manufacturers - Specialty & Generic 3.65% 25.66% Grifols, S.A
GRF7.45B Healthcare Drug Manufacturers - General 17.34% 34.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Labiana Health S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Labiana Health S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.92%, the Debt to Equity ratio from the most recent quarter is 1,378.08, and its Gross Profit Margin stands at 147.79%.
- What is the recent revenue and earnings growth for LAB?
- Looking at Labiana Health S.A's growth, its revenue over the trailing twelve months (TTM) was €67M. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.00%, and quarterly earnings saw a YoY growth of N/A.
- How much of LAB stock is held by insiders and institutions?
- Wondering who owns Labiana Health S.A stock? Company insiders (like executives and directors) hold about 72.21% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.11%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.